Serum tumor markers in the management of ovarian, endometrial and cervical cancer

This publication has 122 references indexed in Scilit:

• Can Initial Serum Cyfra 21-1, SCC Antigen, and TPA Levels in Squamous Cell Cervical Cancer Predict Lymph Node Metastases or Prognosis?
  Gynecologic Oncology, 2000
• Is OVX1 a Suitable Marker for Endometrial Cancer?
  Gynecologic Oncology, 1997
• Serum Inhibin and Disease Status in Women with Ovarian Granulosa Cell Tumors
  Gynecologic Oncology, 1997
• Hepatoid Adenocarcinoma of the Endometrium Associated with Alpha-Fetoprotein Production
  International Journal of Gynecological Pathology, 1996
• Preoperative evaluation of macrophage colony-stimulating factor levels in patients with endometrial cancer
  American Journal of Obstetrics and Gynecology, 1996
• Multiple tumour marker assays in advanced cervical cancer: Relationship to chemotherapy response and clinical outcome
  European Journal of Cancer, 1996
• Expression of Vascular Endothelial Growt Factor and Its Receptors fit and KDR in Ovarian Carcinoma
  JNCI: Journal of the National Cancer Institute, 1995
• Diagnostic value of pelvic examination, ultrasound, and serum CA 125 in postmenopausal women with a pelvic mass. An international multicenter study
  Cancer, 1994
• Prospective Multicenter Study on CA 125 in Postmenopausal Pelvic Masses
  Gynecologic Oncology, 1994
• CA 125 serum levels in the early post-operative period do not reflect tumour reduction obtained by cytoreductive surgery
  European Journal of Cancer, 1993